Mesa Biotech Revenue and Competitors

Location

$39.4M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Mesa Biotech's estimated annual revenue is currently $3.2M per year.(i)
  • Mesa Biotech's estimated revenue per employee is $77,500
  • Mesa Biotech's total funding is $39.4M.

Employee Data

  • Mesa Biotech has 41 Employees.(i)
  • Mesa Biotech grew their employee count by -35% last year.

Mesa Biotech's People

NameTitleEmail/Phone
1
CFOReveal Email/Phone
2
VP Engineering & Product DevelopmentReveal Email/Phone
3
Co-Founder & Chief Scientific OfficerReveal Email/Phone
4
Co-Founder & Chief Technology OfficerReveal Email/Phone
5
Manager, ManufacturingReveal Email/Phone
6
Supervisor, Protein BiochemistryReveal Email/Phone
7
Quality Operations/Continuous Improvement LeadershipReveal Email/Phone
8
Manufacturing Engineer 1Reveal Email/Phone
9
Chairman Reveal Email/Phone
10
President and CEOReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Mesa Biotech?

Mesa Biotech designs, develops, manufactures and commercializes next generation molecular diagnostic tests, bringing the superior diagnostic performance of nucleic acid PCR amplification to the point-of-care. Mesaᅢᄁ¬ツᆲ¬トᄁs Acculaᅢᄁ¬ダᅡᄁ System consists of a portable, palm-sized dock and assay-specific test cassettes. This patented system enables healthcare professionals to access actionable, laboratory-quality results at the point-of-care with greater sensitivity and specificity than current infectious disease rapid immunoassay tests. The Accula Flu A/Flu B and the Accula RSV tests have obtained CE Mark in the EU and 510(k) clearance and Clinical Laboratory Improvements Amendments (CLIA) waiver from the U.S. Food and Drug Administration (FDA).

keywords:N/A

$39.4M

Total Funding

41

Number of Employees

$3.2M

Revenue (est)

-35%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Mesa Biotech News

2022-04-17 - Steerable microcatheter nets FDA 510(k) clearance for ...

Roche Diagnostics, Beckman Coulter, BioMérieux, Mesa Biotech Receive FDA 510(k) Clearances in November. staff reporter, 360Dx, 2020.

2022-04-17 - Laboratory-Developed Tests (LDTs) Market SWOT Analysis ...

Laboratory-Developed Tests (LDTs) Market SWOT Analysis, Key Indicators and Top Key Vendors (Roche, Quidel, Mesa Biotech) | Forecast to 2029.

2022-04-17 - Global COVID-19 Diagnosis Market Revenue Analysis and ...

Global COVID-19 Diagnosis Market Revenue Analysis and Industry Forecast, 2022 to 2028 Top Most Key Players Cepheid, Abbott, Mesa Biotech,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$10.1M41-18%N/A
#2
$4.8M418%N/A
#3
$7.5M41-13%$269.2M
#4
$8.9M413%N/A
#5
$6.7M413%N/A